{"SPADE_UN_25889": {"Sequence Information": {"Peptide Name": "LL-37 KR-8 [I3W,V4W,R6W,I7W], W542", "Sequence": "KRWWQWWK", "Sequence Length": 8, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Anti-Mammalian Cell", "Antibiofilm"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P49913", "uniprotUrl": "http://www.uniprot.org/uniprot/P49913", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "Enhanced Antimicrobial Screening Sensitivity Enabled the Identification of an Ultrashort Peptide KR-8 for Engineering of LL-37mini to Combat Drug-Resistant Pathogens.", "Pubmed ID": "37812567", "Reference": "ACS Infect Dis. 2023;9:2215-2225", "Author": "Mechesso AF, Su Y, Xie J, Wang G", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37812567"}, {"Title": "Segment-Based Peptide Design Reveals the Importance of N-Terminal High Cationicity for Antimicrobial Activity Against Gram-Negative Pathogens", "Pubmed ID": "39377976", "Reference": "Probiotics Antimicrob Proteins. 2024;doi: 10.1007/s12602-024-10376-3:", "Author": "Mechesso AF, Zhang W, Su Y, Xie J, Wang G", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/39377976"}], "Mass": 1303.51, "PI": 11.17, "Net Charge": 3, "Hydrophobicity": -2.42, "Frequent Amino Acids": "WKQ", "Absent Amino Acids": "ACDEFGHILMNOPSTUVY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 0, "Polar Residues": 8, "Positive Residues": 3, "Negative Residues": 0, "SPADE ID": "SPADE_UN_25889", "Similar Sequences": [{"SPADE_ID": "SPADE_N_13941", "Similarity": 1.0, "Sequence": "GHYCNFSVTPKFKRW"}, {"SPADE_ID": "SPADE_N_14187", "Similarity": 1.0, "Sequence": "AGTEKIFNRLKKTINEGKKIAKRWW"}, {"SPADE_ID": "SPADE_UN_02273", "Similarity": 1.0, "Sequence": "RGFWMKRWW"}], "Hemolytic Activity": "Human keratinocytes HaCat:50% Cell death=>100 µM,Human erythrocytes:18% Hemolysis=400 µM,Human keratinocytes HaCat:25% Cytotoxicity=100 µM", "Target Organism": "Staphylococcus aureus USA 300 LAC(MIC=8µM),Escherichia coli E423-17(MIC=4µM),Pseudomonas aeruginosa E411-17(MIC=8µM),Klebsiella pneumoniae E406-17(MIC=>32µM),Acinetobacter baumannii B28-16(MIC=32µM),Staphylococcus aureus USA 300 LAC(MIC=>32µM),Staphylococcus aureus USA 300 LAC(MIC=16µM),Pseudomonas aeruginosa E411-17(MIC=16µM),Pseudomonas aeruginosa E411-17(MIC=>32µM),Staphylococcus epidermidis 1457(MIC=16µM),Human hepatocellular carcinoma HepG2(50-60% Cytotoxicity=12-100µM),Human lung carcinoma A549(10-20% Cytotoxicity=100µM)"}}}